Christin L. Melton, ELS | Authors


Melanoma Investigators Strive to Overcome PD-1 Inhibitor Resistance

May 17, 2019

Investigators across the globe have expended considerable effort attempting to identify mechanisms of response and resistance to ICIs. The general conclusion is that each patient’s response to immunotherapy is likely complex and highly individualized.

A Little STING May Enhance the Immune System Against Cancer

April 25, 2015

Despite their promise, checkpoint inhibitors are not effective in every patient, and research suggests the STING (stimulator of interferon genes) pathway may hold important clues as to why some tumors fail to respond.